Atlas Trials

Efficacy and Safety of a Drinkable Nutraceutical for Hair Loss in Patients Using GLP-1/GIP Receptor Agonists

Clinical trial NCT07484061 · RECRUITING

Trial details

NCT number
NCT07484061
Sponsor
Olistic Research Labs S.L.
Status
RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Telogen Effluvium
Start date
2026-03-16
Primary completion
2026-08-31
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.